Clinical Trial Update: Gemcitabine+ Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing gemcitabine plus capecitabine versus capecitabine alone in curatively resected biliary tract cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine/Capecitabine (Gemcitabine/Capecitabine)

Snippet

Sponsor: Samsung Medical Center | Conditions: Biliary Tract Cancer | Phase 3 | Status: UNKNOWN